Page last updated: 2024-08-26

fulvestrant and nvp-cgm097

fulvestrant has been researched along with nvp-cgm097 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Alexandrou, S; Caldon, CE; Chia, KM; Coulson, R; Fernandez, KJ; Halilovic, E; Haupt, S; Haupt, Y; Lim, E; Milioli, HH; Parker, A; Portman, N; Segara, D; Swarbrick, A; Tilley, WD; Yong, A	1

Other Studies

1 other study(ies) available for fulvestrant and nvp-cgm097

Article	Year
MDM2 inhibition in combination with endocrine therapy and CDK4/6 inhibition for the treatment of ER-positive breast cancer. Breast cancer research : BCR, 2020, 08-12, Volume: 22, Issue:1 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase 6; Drug Resistance, Neoplasm; Female; Fulvestrant; Humans; Isoquinolines; Mice; Mice, Inbred NOD; Mice, SCID; Piperazines; Proto-Oncogene Proteins c-mdm2; Pyridines; Receptors, Estrogen; Xenograft Model Antitumor Assays	2020

Article

Year

MDM2 inhibition in combination with endocrine therapy and CDK4/6 inhibition for the treatment of ER-positive breast cancer.

Breast cancer research : BCR, 2020, 08-12, Volume: 22, Issue:1

Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase 6; Drug Resistance, Neoplasm; Female; Fulvestrant; Humans; Isoquinolines; Mice; Mice, Inbred NOD; Mice, SCID; Piperazines; Proto-Oncogene Proteins c-mdm2; Pyridines; Receptors, Estrogen; Xenograft Model Antitumor Assays

2020